Redhill Biopharma
RDHL
21 hedge funds and large institutions have $27.3M invested in Redhill Biopharma in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
29% more capital invested
Capital invested by funds: $21.2M → $27.3M (+$6.09M)
5% less funds holding
Funds holding: 22 → 21 (-1)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
+$1.43M |
| 2 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$378K |
| 3 |
FAM
Fred Alger Management
New York
|
+$83.9K |
| 4 |
Morgan Stanley
New York
|
+$69.9K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.17M |
| 2 |
BC
Broadfin Capital
New York
|
-$280K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$228K |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$14K |
| 5 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$228K | -21 | Closed |
|
RDHL Hedge Fund Activity: Q3 2016 in Review
21 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2016, worth a combined $27.3M — up 29% from $21.2M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of RDHL and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 3 added.
The largest buyer was Bank Hapoalim BM, adding an estimated $1.43M. The largest seller was Sabby Management, cutting an estimated $1.17M.
- 21 institutional investors held Redhill Biopharma (RDHL) as of Q3 2016, down from 22 in Q2 2016.
- Funds reported $27.3M of Redhill Biopharma stock for Q3 2016, up 29% quarter-over-quarter.
- 2 funds opened new Redhill Biopharma positions in Q3 2016 and 3 closed out, a net change of -1 holder.
- The largest Redhill Biopharma buyer in Q3 2016 was Bank Hapoalim BM, an estimated $1.43M added.
- The largest Redhill Biopharma seller in Q3 2016 was Sabby Management, an estimated $1.17M sold.
Based on aggregated 13F filings for Q3 2016.